Susan Desmond-Hellmann

Susan Desmond-Hellmann
Name	Susan Desmond-Hellmann
Birth date	1958
Birth place	San Francisco, California, U.S.
Occupation	Physician, oncologist, biotech executive, academic administrator
Known for	Leadership at Genentech, Chancellor of the University of California, San Francisco, President of the Bill & Melinda Gates Foundation

Susan Desmond-Hellmann is an American physician, oncologist, and biotechnology executive known for leadership roles across academic medicine, industry, and philanthropy. She served in executive positions at Genentech, led the University of California, San Francisco as Chancellor, and was President of the Bill & Melinda Gates Foundation. Her career spans clinical research, drug development, and global health policy collaborations with governments and international organizations.

Early life and education

Desmond-Hellmann was born in San Francisco and raised in the San Francisco Bay Area, where she attended local schools before matriculating at the University of California, Berkeley and later earning an M.D. from the University of California, San Francisco School of Medicine. She completed residency and fellowship training in internal medicine and oncology at institutions affiliated with UCSF Medical Center and clinical research programs linked to National Institutes of Health investigators. During her training she worked with researchers connected to American Cancer Society initiatives and learned translational research methods used at centers such as Dana–Farber Cancer Institute and Fred Hutchinson Cancer Center.

Medical and academic career

Desmond-Hellmann began her academic career as a faculty physician and investigator at University of California, San Francisco, where she held appointments in clinical oncology and participated in cooperative groups such as the American Association for Cancer Research and the American Society of Clinical Oncology. Her research focused on cancer immunology and clinical trials informed by biomarker strategies developed at institutions like Memorial Sloan Kettering Cancer Center and Johns Hopkins University School of Medicine. As an academic leader she engaged with peers from Stanford University School of Medicine, Harvard Medical School, and Columbia University Irving Medical Center on curriculum, faculty recruitment, and interdisciplinary programs linking clinical services at UCSF Medical Center with basic science at the Howard Hughes Medical Institute.

Career at Genentech and biotechnology leadership

In industry, she joined Genentech, where she advanced to roles including Chief Medical Officer and head of product development, overseeing clinical programs and regulatory strategy in collaboration with agencies such as the Food and Drug Administration and multinational partners including Roche. At Genentech she led teams that developed oncology and immunotherapy agents alongside scientific collaborators from University of California, Los Angeles, Massachusetts Institute of Technology, and University of Cambridge. Her tenure intersected with biotechnology peers and competitors such as Amgen, Biogen, Pfizer, and Merck & Co., and she participated in industry consortia with the National Cancer Institute and philanthropic funders like the Bill & Melinda Gates Foundation.

Tenure as President of the Bill & Melinda Gates Foundation

As President of the Bill & Melinda Gates Foundation, she directed global programs spanning vaccine development, infectious disease control, and health systems strengthening, coordinating with organizations such as the World Health Organization, Gavi, the Vaccine Alliance, and UNICEF. She prioritized partnerships with national ministries of health in countries like India, Kenya, and Nigeria and collaborated with research institutions including London School of Hygiene & Tropical Medicine and Imperial College London. Her leadership engaged donors and policymakers from the United Nations and World Bank and intersected with initiatives by the Global Fund to Fight AIDS, Tuberculosis and Malaria and private-sector collaborators including Bill Gates-backed technology and pharmaceutical partners.

Board memberships, honors, and awards

Desmond-Hellmann has served on corporate and nonprofit boards including Facebook (now Meta Platforms), Pfizer, and academic advisory boards tied to UCSF, Berkeley, and the Haas School of Business. She has been recognized by organizations such as the National Academy of Medicine, the American Association for the Advancement of Science, and received awards from entities including the American Cancer Society and professional societies like the American Society of Clinical Oncology. Her advisory roles connected her with leaders from Microsoft, Alphabet Inc., and philanthropic networks anchored by the Rockefeller Foundation and Ford Foundation.

Personal life and philanthropy

Her personal life includes partnerships and family ties in the San Francisco Bay Area, and philanthropic support for medical research, higher education, and global health initiatives. She has contributed to fundraising and endowment efforts at institutions such as University of California, San Francisco, University of California, Berkeley, and public health programs at Harvard T.H. Chan School of Public Health, while engaging with nonprofit partners including PATH, Clinton Foundation, and regional community health organizations.

Category:1958 births Category:American oncologists Category:University of California, San Francisco faculty Category:Genentech people Category:American nonprofit executives